PCL Buttock Injections

Ingredient: 331mg/ml polycaprolactone, Sodium carboxymethyl cellulose, Glycerin, Sodium chloride, Phosphate buffer

Specification: 1ml

Package: Single package

Application Area: Used for subcutaneous deep injection of nasal base, nasolabial groove, nose, jaw, eyebrow arch, outer contour, etc.



Contact Now WhatsApp
Product Details

Product Introduction:

The osmotic pressure of our product ranges from 200-400 mOsm/kg, significantly lower than the 600 mOsm/kg found in most marketed products. This physiologically closer osmotic pressure helps minimize post-injection swelling and redness, improving patient comfort.

Our product also requires less injection force, making it easier to administer. This ensures a smoother, faster treatment experience for both doctors and patients, ultimately reducing procedure duration.

Thanks to its superior viscoelastic properties, our product has demonstrated excellent improvement effects on the nasal base, brow ridge, and outer facial contour.


Product Display:

PCL Buttock Injections


Product Details:

Type

PCL Filler

Ingredient

331mg/ml polycaprolactone, sodium carboxymethyl cellulose, glycerin, sodium chloride, phosphate buffer

Specification

1ml

Effect area

Deep dermis

Application area

Used for subcutaneous deep injection of nasal base, nasolabial groove, nose, jaw, eyebrow arch, outer contour, etc

How to choose

Moderate to severe naso-lip wrinkles

Package

Single package

Storage

Cool, dry environment

Recommended
Use quantity

1-2 pc/time

Recommended interval

12 months

Lasting time

12 months

Microsphere size

25-50μm

Extruding force

12N 


Product Package:

PCL Buttock Injections


Product Effects:

Product Effects


Customer Feedback:

Customer Feedback

Customer Feedback


Raw Material Advantages:

1. Our product has an elastic modulus of 350Pa, which is higher than the 180Pa of marketed products, providing superior viscoelasticity. This results in more defined shaping and filling effects while reducing the risk of displacement.

2. With an HA content of 20-24 mg/g, our product offers a greater variety of options and can be customized based on user needs.

3. Due to differences in microsphere types, the degradation time and rate are determined by the properties of the microspheres. Polycaprolactone (PCL) microspheres have a longer duration of action compared to block copolymer microspheres, ensuring more prolonged results.

With a wider range of applications, our product has been shown to effectively improve areas such as the nose, jawline, tear troughs, and temples.


Development Process:

Development Process

Development Process


Company Introduction:

Our medical-grade material modification and functionalization platform is backed by 15 years of expertise in polysaccharide material modification and crosslinking, enabling the transformation of chitosan into carboxymethyl chitosan (commercially available as an anti-adhesion surgical solution) and sodium hyaluronate into crosslinked sodium hyaluronate, utilizing advanced biphasic, monophasic, and micro-crosslinking techniques. Additionally, our medical-grade microsphere preparation technology encompasses crosslinked starch microspheres (already commercialized as a composite microporous polysaccharide hemostatic powder), solvent-free injectable PCL, innovative emulsification-based injectable PLLA, and precision-engineered injectable PMMA microspheres.


Factory Equipment:

Factory Equipment

Factory Equipment


Leave your messages

Related Products

x

Popular products

x